Sign in
CompletedNo phase

Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
210 people enrolled
Started
1 May 2025
Ended
1 Dec 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 0.9% normal saline
  • Metoclopramide 10mg
  • Dexamethasone
Record updated
21 October 2026

Who can take part

Age
40 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age: 40-80 years, both sexes
  • ASA physical status class I to III
  • Apfel score 0-2

Who cannot take part

  • patients taking medications with known antiemetic activity
  • previous postoperative vomiting
  • history of motion sickness
  • patients with gastrointestinal disorders or gastro-oesophageal reflux
  • allergy to bupivacaine
  • allergy to metoclopramide or dexamethasone

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Postoperative nausea and vomiting (PONV) is a common consequence of ambulatory surgery, affecting up to 80% of high-risk patients and 20-30% overall. Despite being widespread, a prior survey found that patients are more averse to PONV than pain and other significant postoperative problems. Furthermore, even mild cases of PONV can have serious repercussions, such as postanesthesia care unit (PACU) workflow disruption, delayed discharges, higher medical costs, and lower patient satisfaction.PONV following intraocular surgery can be unpleasant and may lead to serious complications including suprachoroidal hemorrhage (SCH). SCH is a potentially serious condition that occurs when the posterior ciliary arteries or vortex veins burst, resulting in blood in the suprachoroidal region.

Read full original descriptionShow less

The hypothesis is that dexamethasone will lower the incidence of PONV after cataract surgery when compared with metoclopramide.

The 3 groups in the trial

  • group pPlacebo, for comparison

    patients will receive 0.9% normal saline

    Treatment: 0.9% normal saline

  • group MExisting treatment, for comparison

    patients will receive 10 mg metoclopramide

    Treatment: Metoclopramide 10mg

  • group DExisting treatment, for comparison

    patients will receive 8 mg dexamethasone

    Treatment: Dexamethasone

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract Surgery: A Double-blind Randomized Controlled Study
Record updated
21 October 2026